Efficacy of buspirone in smoking cessation: a placebo-controlled trial

Clinical Pharmacology and Therapeutics
N G SchneiderH V Brown

Abstract

Buspirone, a non-sedating anxiolytic, has yielded contradictory results in smoking cessation pilot studies and trials. We tested buspirone (n = 51) versus placebo (n = 49) in a placebo-controlled, double-blind trial of smoking cessation. Survival analyses were performed with use of strict abstinence criteria for efficacy (carbon monoxide levels < or = 8 ppm; no self-reported slips to smoking). No treatment differences were observed between active and placebo groups. There were also no differences among "anxiety" level groups formed post hoc from high versus low, pre-quit anxiety test scores. A number of withdrawal symptoms increased significantly after subjects quit smoking for both the active drug and placebo groups, but these symptoms were not relieved by treatment. There appears to be little evidence that buspirone is effective in smoking cessation or in the relief of withdrawal associated with cessation in a general sample. Selecting for generalized anxiety or anxiety related to cessation is suggested for future testing.

References

Jul 1, 1991·Neuropeptides·D P Taylor, S L Moon
Feb 11, 1992·Archives of Internal Medicine·D E HillemanM H Sketch
Jan 1, 1989·Psychopharmacology·J Gross, M L Stitzer
Apr 1, 1989·Journal of Behavioral Medicine·K O Fagerstrom, N G Schneider
Mar 1, 1989·Archives of General Psychiatry·F GawinR Byck
Jan 1, 1988·Pharmacotherapy·M W Jann
Jan 1, 1984·Addictive Behaviors·N G SchneiderA B Forsythe
Oct 9, 1995·Archives of Internal Medicine·M Law, J L Tang
Feb 23, 1994·JAMA : the Journal of the American Medical Association·S L KenfordT B Baker

❮ Previous
Next ❯

Citations

Jan 5, 2002·Pharmacotherapy·M KotlyarB D Jamerson
May 25, 2011·Drug Design, Development and Therapy·José Juan Escobar-ChávezIsabel Marlen Rodríguez-Cruz
Jan 23, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Nancy K MelloStephen J Kohut
Mar 25, 2014·Expert Opinion on Emerging Drugs·Muhamad Y Elrashidi, Jon O Ebbert
Dec 24, 2013·The American Journal of Drug and Alcohol Abuse·Neil E PatersonEdythe D London
Nov 5, 2015·Journal of Psychosocial Nursing and Mental Health Services·Robert H Howland
Mar 16, 2001·Expert Opinion on Pharmacotherapy·S V Culpitt, D F Rogers
Jul 26, 2012·The International Journal of Neuropsychopharmacology·Jack BergmanPhil Skolnick
Jan 16, 2004·Trends in Pharmacological Sciences·Tony P George, Stephanie S O'Malley
Aug 7, 1999·Primary Care·L H Ferry
Jan 7, 1999·The Annals of Pharmacotherapy·P Farid, M A Abate
Oct 18, 2000·The Cochrane Database of Systematic Reviews·J R HughesT Lancaster
Feb 6, 1999·Journal of Clinical Psychopharmacology·J T Apter, L A Allen
Oct 16, 2002·Oncogene·Caryn Lerman, Raymond Niaura
Dec 19, 2017·Pharmacotherapy·Nieves Gómez-CoronadoSeetal Dodd
Nov 18, 2009·Pharmacology & Therapeutics·Bianca Jupp, Andrew J Lawrence

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.